BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25875595)

  • 1. Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation.
    Kornej J; Schmidl J; Ueberham L; John S; Daneschnejad S; Dinov B; Hindricks G; Adams V; Husser D; Bollmann A
    PLoS One; 2015; 10(4):e0123574. PubMed ID: 25875595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Galectin-3 and Atrial Fibrillation Recurrence after Catheter Ablation: A Meta-Analysis.
    Zhang G; Wu Y
    Cardiovasc Ther; 2019; 2019():4148129. PubMed ID: 31772609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation.
    Begg GA; Karim R; Oesterlein T; Graham LN; Hogarth AJ; Page SP; Pepper CB; Rhode K; Lip GYH; Holden AV; Plein S; Tayebjee MH
    Europace; 2017 Dec; 19(12):1944-1950. PubMed ID: 28339804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease.
    Wu XY; Li SN; Wen SN; Nie JG; Deng WN; Bai R; Liu N; Tang RB; Zhang T; Du X; Dong JZ; Ma CS
    Europace; 2015 Oct; 17(10):1541-7. PubMed ID: 25921557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with nonvalvular atrial fibrillation.
    Miake J; Kato M; Ogura K; Iitsuka K; Okamura A; Tomomori T; Tsujimoto D; Kato M; Yamamoto K
    Heart Vessels; 2019 Mar; 34(3):517-526. PubMed ID: 30238353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences.
    Kornej J; Hindricks G; Banerjee A; Arya A; Sommer P; Rolf S; Husser D; Lip GY; Bollmann A
    Heart; 2015 Jan; 101(2):126-31. PubMed ID: 25281600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation.
    Kornej J; Hindricks G; Shoemaker MB; Husser D; Arya A; Sommer P; Rolf S; Saavedra P; Kanagasundram A; Patrick Whalen S; Montgomery J; Ellis CR; Darbar D; Bollmann A
    Clin Res Cardiol; 2015 Oct; 104(10):871-6. PubMed ID: 25876528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Galectin-3 and Aldosterone for Predicting Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation.
    Ruan ZB; Gao RF; Wang F; Chen GC; Zhu JG; Ren Y; Zhu L
    Cardiovasc Ther; 2022; 2022():6993904. PubMed ID: 35692374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation.
    Berger WR; Jagu B; van den Berg NWE; Chan Pin Yin DRPP; van Straalen JP; de Boer OJ; Driessen AHG; Neefs J; Krul SPJ; van Boven WP; van der Wal AC; de Groot JR
    Europace; 2018 May; 20(5):764-771. PubMed ID: 28525549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The APPLE Score - A Novel Score for the Prediction of Rhythm Outcomes after Repeat Catheter Ablation of Atrial Fibrillation.
    Kornej J; Hindricks G; Arya A; Sommer P; Husser D; Bollmann A
    PLoS One; 2017; 12(1):e0169933. PubMed ID: 28085921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study.
    Begg GA; Karim R; Oesterlein T; Graham LN; Hogarth AJ; Page SP; Pepper CB; Rhode K; Lip GYH; Holden AV; Plein S; Tayebjee MH
    PLoS One; 2018; 13(1):e0189936. PubMed ID: 29293545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
    Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial strain is a powerful predictor of atrial fibrillation recurrence after catheter ablation: study of a heterogeneous population with sinus rhythm or atrial fibrillation.
    Yasuda R; Murata M; Roberts R; Tokuda H; Minakata Y; Suzuki K; Tsuruta H; Kimura T; Nishiyama N; Fukumoto K; Aizawa Y; Tanimoto K; Takatsuki S; Abe T; Fukuda K
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):1008-14. PubMed ID: 25750193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry.
    Deng H; Shantsila A; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Liu Y; Wei W; Fu L; Xue Y; Wu S; Lip GYH
    Arch Cardiovasc Dis; 2019 Mar; 112(3):171-179. PubMed ID: 30683618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure.
    Clementy N; Garcia B; André C; Bisson A; Benhenda N; Pierre B; Bernard A; Fauchier L; Piver E; Babuty D
    PLoS One; 2018; 13(8):e0201517. PubMed ID: 30067817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preablation monocyte/ high density lipoprotein ratio predicts the late recurrence of paroxysmal atrial fibrillation after radiofrequency ablation.
    Chen SA; Zhang MM; Zheng M; Liu F; Sun L; Bao ZY; Chen FK; Li HX; Gu X
    BMC Cardiovasc Disord; 2020 Sep; 20(1):401. PubMed ID: 32894051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.